Mounjaro®
Starting from £179.99/mo
Start journey Learn moreAnxiety attacks are not listed as a common side effect of Mounjaro (tirzepatide) in the UK prescribing information, though some people do report feeling anxious, shaky or unsettled, particularly in the first weeks of treatment. Understanding why this happens (and when it warrants urgent attention) matters. Mounjaro is a prescription-only medicine, and any unexpected symptoms during treatment should be discussed with your prescriber. The NHS medicines page for tirzepatide is a reliable first reference for what to expect.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture this: you are a few weeks into treatment, you have been eating far less than usual because appetite has fallen sharply, and one afternoon you notice your hands shaking, your chest feeling tight, and a creeping sense of dread you cannot quite explain. It feels like panic. Before assuming Mounjaro itself is triggering anxiety attacks, it is worth pulling apart what is actually going on physiologically, and the question of whether Mounjaro can cause anxiety is one we address in detail for anyone wanting a thorough answer.
The most common culprit is a rapid drop in blood sugar. Even in people without diabetes, eating significantly less while the body adjusts to tirzepatide can push glucose lower than usual. The physical signs of mild hypoglycaemia (trembling, a pounding heart, sweating, dizziness, a vague sense of doom) are almost indistinguishable from a panic attack. Eating a small amount of fast-acting carbohydrate and waiting fifteen minutes often resolves the episode entirely. If it does, that points firmly toward blood sugar rather than an anxiety disorder.
Dehydration is a second factor. Nausea and reduced appetite can mean people drink less than they realise. Even mild dehydration raises heart rate and makes the body feel on edge. Caffeine sensitivity also tends to increase when food intake drops, so the same morning coffee that caused no trouble before treatment can feel much more stimulating now. These are practical explanations, not reasons to dismiss what you experienced, it genuinely felt alarming, and that is understandable.
For a fuller picture of everything this medicine can cause, the Mounjaro side effects overview covers the full GI and non-GI profile in detail.
Mounjaro's UK Summary of Product Characteristics (the formal clinical document that lists every identified adverse effect) does not include anxiety, panic attacks or any anxiety-spectrum condition in its adverse reactions table. This matters because the clinical trial programme was large enough that a consistent anxiety signal would have been captured. The absence is informative, not a gap.
That said, individual experience varies. Some people report heightened emotional sensitivity, irritability or low mood, particularly during the first four to six weeks or around dose increases. These effects are not well characterised in the literature for tirzepatide specifically. If you are noticing a pattern (symptoms arriving at roughly the same point in the week, for example, or clustering around the dose day) keeping a simple log and sharing it at your next clinical review gives the prescriber something concrete to work with.
There is a separate and important consideration for anyone whose anxiety is linked to food, eating or body image. GLP-1 medicines change hunger signals significantly, and for some people that shift brings unexpected emotional responses. The charity Beat provides support for anyone finding the psychological side of eating and weight difficult to navigate.
Questions about anxiety and tirzepatide more broadly, including the mechanism side, are explored further on the tirzepatide and anxiety page.
A small proportion of people on Mounjaro experience a raised resting heart rate, particularly early in treatment. Tachycardia (a fast heartbeat) can feel very much like the physical component of a panic attack. If your heart is consistently racing between doses, or you notice palpitations that do not settle within a few minutes, that warrants a conversation with your prescriber rather than waiting it out.
Low mood and thoughts of self-harm are listed in safety monitoring guidance for GLP-1 medicines. The MHRA and NHS ask prescribers and patients to be alert to these symptoms and to report them via the Yellow Card scheme. If you experience a sudden change in mood, persistent low mood, or any thoughts of harming yourself, please contact your prescriber, call NHS 111, or in an emergency call 999. This is not a reason to avoid treatment, but it is a reason to take new psychological symptoms seriously rather than attributing everything to stress or adjustment.
For detailed questions about what sits behind anxiety-type sensations during treatment, the reasons Mounjaro can cause anxiety-like feelings page goes deeper on the physiological pathways.
Most anxiety-adjacent symptoms on Mounjaro improve as the body settles, usually within the first month or after a dose stabilises. Practical steps that often help: eating a small amount of protein with every meal even when appetite is low, keeping a water bottle in reach throughout the day, and spacing caffeine intake carefully. Timing matters too, some patients find that scheduling their injection on a consistent day each week (not the morning before a busy Monday, for instance, or right before a bank holiday when it is harder to reach support) makes managing early side effects feel more manageable.
If symptoms are severe, recurring across multiple weeks, or affecting your daily functioning, contact your prescriber promptly. At nume, a clinical support team is available seven days a week for exactly this kind of concern. You do not need to wait until your next scheduled review.
People considering treatment and wanting to understand the full picture first can read about Mounjaro as a whole, or explore how it fits alongside other options on the weight-loss treatments overview. And if cost is part of the decision, the Mounjaro cost context page explains what private treatment typically includes and what headline prices sometimes leave out.
If you would like a prescriber to review your full medical history and advise on whether Mounjaro is right for you, check your eligibility with a free consultation, reviewed the same day by a real clinician, not software.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.